The pre-seed round was led by Fusion Fund to help expand operations into the United States.
"We are incredibly privileged to have Fusion Fund as our lead investor and are truly humbled by their belief in our vision. This partnership marks an exciting opportunity to expand into the US market and scale globally together. We are deeply committed to redefining safety in autonomous systems, and it’s inspiring to have a partner like Fusion Fund share our confidence in what we’re building."
The investment forms part of a £1m round backed by The FSE Group and Waterspring Ventures.
"This funding is allowing us to invest in key activities to accelerate our growth trajectory and solidify our position in the market. Planned developments mean we can continue to provide customers with unparalleled insights at exceptional value. We are excited to partner with The FSE Group and South West Investment Fund as we continue to expand our capabilities and enhance our platform."
The financing round was co-led by Radical Ventures and Sofinnova Partners to accelerate the development of programmable biology tools.
"Every biotechnology or pharmaceutical company wants to be at the forefront of technology to find the best therapeutic molecules, yet not all are in a position to develop the most advanced AI models for the job. That’s where Latent Labs comes in. We push the frontiers of generative biology, giving our partners instant access to tools that accelerate their drug design programs."
Senvest Capital led the pre-seed round for the sales artificial intelligence startup.
"After exploring different ways to leverage AI in our activities, we have found that Breakthrough gives B2B marketing teams like us the perfect mix of predetermined campaign goals and automated customer research—allowing for scalable, high-quality, customer communication campaigns to be produced in no time. The integration of AI-driven insights with strategic marketing goals is exactly what B2B marketers need to run smarter, faster, and more targeted campaigns."
The round was led by Growth Equity at Goldman Sachs Alternatives and values the company at $1.1bn.
"By connecting people to the AI, data, and systems they need to do their best work, the opportunity before us at Tines is to become the universal orchestrator of modern, secure workflows across the enterprise. This new round will help us realise that opportunity."